Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,410
Sort by:
Female Sexual Dysfunction - Pipeline Review, H1 2020
US$ 2,000.00
... . The Female Sexual Dysfunction (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Sexual Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
84 pages
Retinal Vein Occlusion - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinal Vein Occlusion (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinal Vein Occlusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
93 pages
Age Related Macular Degeneration - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Age Related Macular Degeneration (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Age Related Macular Degeneration and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
864 pages
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bile Duct Cancer (Cholangiocarcinoma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
1561 pages
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Kidney Cancer (Renal Cell Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
2815 pages
Ovarian Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Ovarian Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
3802 pages
Wounds - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Wounds - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Wounds (Dermatology), complete with analysis by stage of development ...
June 2020
255 pages
Neuroendocrine Tumors - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Neuroendocrine Tumors (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Neuroendocrine Tumors and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
795 pages
Keloids - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Keloids (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Keloids and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
64 pages
Peptic Ulcers - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Peptic Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Peptic Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
65 pages
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pituitary ACTH Hypersecretion (Cushing Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
42 pages
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinitis Pigmentosa (Retinitis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
260 pages
Recurrent Malignant Glioma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Recurrent Malignant Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Recurrent Malignant Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
55 pages
Progressive Supranuclear Palsy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Progressive Supranuclear Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Progressive Supranuclear Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
113 pages
Western Equine Encephalitis - Pipeline Review, H1 2020
US$ 2,000.00
... . The Western Equine Encephalitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Western Equine Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
33 pages
Radiodermatitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Radiodermatitis (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiodermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
57 pages
Canavan Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Canavan Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Canavan Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
35 pages
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Cervical Intraepithelial Neoplasia (CIN) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Cervical Intraepithelial Neoplasia (CIN) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
282 pages
Encephalopathy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Encephalopathy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
81 pages
Familial Amyloid Neuropathies - Pipeline Review, H1 2020
US$ 2,000.00
... . The Familial Amyloid Neuropathies (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Familial Amyloid Neuropathies and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
98 pages
Graves' Ophthalmopathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Graves' Ophthalmopathy (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Graves' Ophthalmopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
82 pages
Hyperglycemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hyperglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
35 pages
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Liver Failure (Hepatic Insufficiency) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Failure (Hepatic Insufficiency) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
103 pages
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Metachromatic Leukodystrophy (MLD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
68 pages
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
110 pages
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under ...
June 2020
98 pages
Myocardial Fibrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myocardial Fibrosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
87 pages
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
327 pages
Poliomyelitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Poliomyelitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Poliomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
91 pages
Sicca Syndrome (Sjogren) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Sicca Syndrome (Sjogren) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Sicca Syndrome (Sjogren) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
189 pages
Toxoplasmosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Toxoplasmosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Toxoplasmosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
48 pages
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections and features dormant and discontinued projects. The guide covers therapeutics under ...
June 2020
60 pages
Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Anemia in Chronic Kidney Disease (Renal Anemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
152 pages
Dengue Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Dengue Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Dengue Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
179 pages
Female Contraception - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Female Contraception (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Contraception and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
92 pages
Gaucher Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gaucher Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gaucher Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
105 pages
Meningitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Meningitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Meningitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
76 pages
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Multiple Myeloma (Kahler Disease) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Multiple Myeloma (Kahler Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
2289 pages
Pertussis (Whooping Cough) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Pertussis (Whooping Cough) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
127 pages
Bullous Pemphigoid - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bullous Pemphigoid (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Bullous Pemphigoid and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
139 pages
Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Globoid Cell Leukodystrophy (Krabbe Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
77 pages
Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ornithine-Transcarbamylase Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ornithine-Transcarbamylase Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
53 pages
Graves Diseases - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Graves Diseases (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Graves Diseases and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
75 pages
Heart Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... therapeutics under Development by Companies/Universities/Institutes, Heart Transplant Rejection - Pipeline Review, H1 2018 Reference Code: GMDHC10549IDBPublication Date: June 2018 Heart Transplant Rejection (Immunology) pipeline guide helps in identifying and tracking emerging players ...
June 2020
33 pages
Hyperinsulinemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hyperinsulinemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperinsulinemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
77 pages
Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H7N9 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
136 pages
Merkel Cell Carcinoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Merkel Cell Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Merkel Cell Carcinoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
535 pages
